To the best of our knowledge, our study is the first to suggest that the sIL-8 level acts as a potential predictor for LNM and tumor recurrence for gastric cancer, especially in patients with negative CEA, although further prospective studies are warranted. Here, CEACAM5 is linked to gastric cancer.